KOD
Kodiak Sciences Inc
NASDAQ: KOD · HEALTHCARE · BIOTECHNOLOGY
$43.48
-0.44% today
Updated 2026-04-30
Market cap
$2.71B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$3 – $48
Volume
1.2M
Kodiak Sciences Inc (KOD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.05M | $-17.66M | $-29.03M | $-39.15M | $-83.43M | $-182.27M | $-206.46M | $-154.18M | $-117.32M | $-136.01M |
| Capital expenditures | $771000.00 | $209000.00 | $581000.00 | $437000.00 | $7.00M | $63.30M | $47.36M | $41.43M | $400000.00 | $506000.00 |
| Depreciation | $257000.00 | $549000.00 | $490000.00 | $911000.00 | $4.21M | $8.71M | $11.00M | $25.95M | $26.71M | — |
| Stock-based comp | $272000.00 | $275000.00 | $2.67M | $6.11M | $30.67M | $61.38M | $106.03M | $88.56M | $60.21M | $58.86M |
| Free cash flow | $-16.82M | $-17.86M | $-29.61M | $-39.58M | $-90.43M | $-245.57M | $-253.82M | $-195.61M | $-117.72M | $-136.51M |
| Investing cash flow | $-771000.00 | $-209000.00 | $-581000.00 | $-137.00M | $104.83M | $-38.80M | $-336.51M | $249.23M | $-755000.00 | — |
| Financing cash flow | $-120000.00 | $9.64M | $116.47M | $299.69M | $717.38M | $8.18M | $1.90M | $31000.00 | $501000.00 | — |
| Dividends paid | — | — | — | $2.29M | $6.25M | $10.04M | $7.91M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $86.86M | $123.54M | $738.78M | $-212.89M | $-541.08M | — | — | — |